Serveur d'exploration sur la méthode scrum

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems

Identifieur interne : 002C81 ( Istex/Corpus ); précédent : 002C80; suivant : 002C82

Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems

Auteurs : Bálint Kacs H ; Clark E. Grosvenor

Source :

RBID : ISTEX:FC96C32DDC748CD94C0DAA33E26278F261C4A295

English descriptors

Abstract

Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α2‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR. The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α2‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α2‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.

Url:
DOI: 10.1111/j.1365-2826.1991.tb00314.x

Links to Exploration step

ISTEX:FC96C32DDC748CD94C0DAA33E26278F261C4A295

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
<author>
<name sortKey="Kacs H, Balint" sort="Kacs H, Balint" uniqKey="Kacs H B" first="Bálint" last="Kacs H">Bálint Kacs H</name>
<affiliation>
<mods:affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Grosvenor, Clark E" sort="Grosvenor, Clark E" uniqKey="Grosvenor C" first="Clark E." last="Grosvenor">Clark E. Grosvenor</name>
<affiliation>
<mods:affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FC96C32DDC748CD94C0DAA33E26278F261C4A295</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1111/j.1365-2826.1991.tb00314.x</idno>
<idno type="url">https://api.istex.fr/document/FC96C32DDC748CD94C0DAA33E26278F261C4A295/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C81</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
<author>
<name sortKey="Kacs H, Balint" sort="Kacs H, Balint" uniqKey="Kacs H B" first="Bálint" last="Kacs H">Bálint Kacs H</name>
<affiliation>
<mods:affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Grosvenor, Clark E" sort="Grosvenor, Clark E" uniqKey="Grosvenor C" first="Clark E." last="Grosvenor">Clark E. Grosvenor</name>
<affiliation>
<mods:affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Neuroendocrinology</title>
<idno type="ISSN">0953-8194</idno>
<idno type="eISSN">1365-2826</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1991-10">1991-10</date>
<biblScope unit="volume">3</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="529">529</biblScope>
<biblScope unit="page" to="537">537</biblScope>
</imprint>
<idno type="ISSN">0953-8194</idno>
</series>
<idno type="istex">FC96C32DDC748CD94C0DAA33E26278F261C4A295</idno>
<idno type="DOI">10.1111/j.1365-2826.1991.tb00314.x</idno>
<idno type="ArticleID">JNE529</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0953-8194</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cysteamine</term>
<term>clonidine</term>
<term>sexual dimorphism</term>
<term>suckling</term>
<term>thyrotropin‐releasing hormone</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α2‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR. The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α2‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α2‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Bálint Kacsóh</name>
<affiliations>
<json:string>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</json:string>
</affiliations>
</json:item>
<json:item>
<name>Clark E. Grosvenor</name>
<affiliations>
<json:string>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>suckling</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thyrotropin‐releasing hormone</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Cysteamine</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>clonidine</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>sexual dimorphism</value>
</json:item>
</subject>
<articleId>
<json:string>JNE529</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α2‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR. The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α2‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α2‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.</abstract>
<qualityIndicators>
<score>8.5</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>612 x 792 pts (letter)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>5</keywordCount>
<abstractCharCount>3307</abstractCharCount>
<pdfWordCount>7437</pdfWordCount>
<pdfCharCount>43240</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>486</abstractWordCount>
</qualityIndicators>
<title>Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>3</volume>
<publisherId>
<json:string>JNE</json:string>
</publisherId>
<pages>
<total>9</total>
<last>537</last>
<first>529</first>
</pages>
<issn>
<json:string>0953-8194</json:string>
</issn>
<issue>5</issue>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1365-2826</json:string>
</eissn>
<title>Journal of Neuroendocrinology</title>
<doi>
<json:string>10.1111/(ISSN)1365-2826</json:string>
</doi>
</host>
<publicationDate>1991</publicationDate>
<copyrightDate>1991</copyrightDate>
<doi>
<json:string>10.1111/j.1365-2826.1991.tb00314.x</json:string>
</doi>
<id>FC96C32DDC748CD94C0DAA33E26278F261C4A295</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/FC96C32DDC748CD94C0DAA33E26278F261C4A295/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/FC96C32DDC748CD94C0DAA33E26278F261C4A295/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/FC96C32DDC748CD94C0DAA33E26278F261C4A295/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>1991</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
<author>
<persName>
<forename type="first">Bálint</forename>
<surname>Kacsóh</surname>
</persName>
<note type="biography">Permanent address: 2nd Department of Anatomy, Histology and Embryology, Semmelweis University Medical School, Budapest, Hungary 1450.</note>
<note type="biography">: B. Kacsóh, Pennsylvania State University, Department of Molecular and Cell Biology, 401 Althouse Laboratory, University Park, Pennsylvania 16802, USA.</note>
<affiliation>Permanent address: 2nd Department of Anatomy, Histology and Embryology, Semmelweis University Medical School, Budapest, Hungary 1450.</affiliation>
<affiliation>: B. Kacsóh, Pennsylvania State University, Department of Molecular and Cell Biology, 401 Althouse Laboratory, University Park, Pennsylvania 16802, USA.</affiliation>
<affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</affiliation>
</author>
<author>
<persName>
<forename type="first">Clark E.</forename>
<surname>Grosvenor</surname>
</persName>
<affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Journal of Neuroendocrinology</title>
<idno type="pISSN">0953-8194</idno>
<idno type="eISSN">1365-2826</idno>
<idno type="DOI">10.1111/(ISSN)1365-2826</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1991-10"></date>
<biblScope unit="volume">3</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="529">529</biblScope>
<biblScope unit="page" to="537">537</biblScope>
</imprint>
</monogr>
<idno type="istex">FC96C32DDC748CD94C0DAA33E26278F261C4A295</idno>
<idno type="DOI">10.1111/j.1365-2826.1991.tb00314.x</idno>
<idno type="ArticleID">JNE529</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1991</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α2‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR. The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α2‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α2‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>suckling</term>
</item>
<item>
<term>thyrotropin‐releasing hormone</term>
</item>
<item>
<term>Cysteamine</term>
</item>
<item>
<term>clonidine</term>
</item>
<item>
<term>sexual dimorphism</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1991-10">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/FC96C32DDC748CD94C0DAA33E26278F261C4A295/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2826</doi>
<issn type="print">0953-8194</issn>
<issn type="electronic">1365-2826</issn>
<idGroup>
<id type="product" value="JNE"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="JOURNAL OF NEUROENDOCRINOLOGY">Journal of Neuroendocrinology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="10005">
<doi origin="wiley">10.1111/jne.1991.3.issue-5</doi>
<numberingGroup>
<numbering type="journalVolume" number="3">3</numbering>
<numbering type="journalIssue" number="5">5</numbering>
</numberingGroup>
<coverDate startDate="1991-10">October 1991</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="0052900" status="forIssue">
<doi origin="wiley">10.1111/j.1365-2826.1991.tb00314.x</doi>
<idGroup>
<id type="unit" value="JNE529"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="9"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">Full Paper</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2006-09-29"></event>
<event type="publishedOnlineFinalForm" date="2006-09-29"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-16"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-31"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="529">529</numbering>
<numbering type="pageLast" number="537">537</numbering>
</numberingGroup>
<correspondenceTo>
<i>Correspondence to</i>
: B. Kacsóh, Pennsylvania State University, Department of Molecular and Cell Biology, 401 Althouse Laboratory, University Park, Pennsylvania 16802, USA.</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:JNE.JNE529.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<unparsedEditorialHistory>Accepted 15 May 1991</unparsedEditorialHistory>
<countGroup>
<count type="referenceTotal" number="40"></count>
<count type="linksCrossRef" number="4"></count>
</countGroup>
<titleGroup>
<title type="main">Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha
<sub>2</sub>
‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" noteRef="#fn1" corresponding="yes">
<personName>
<givenNames>Bálint</givenNames>
<familyName>Kacsóh</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1">
<personName>
<givenNames>Clark E.</givenNames>
<familyName>Grosvenor</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="a1" countryCode="US">
<unparsedAffiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en">
<keyword xml:id="k1">suckling</keyword>
<keyword xml:id="k2">thyrotropin‐releasing hormone</keyword>
<keyword xml:id="k3">Cysteamine</keyword>
<keyword xml:id="k4">clonidine</keyword>
<keyword xml:id="k5">sexual dimorphism</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α
<sub>2</sub>
‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR.</p>
<p>The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α
<sub>2</sub>
‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α
<sub>2</sub>
‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn1">
<label>1</label>
<p>Permanent address: 2nd Department of Anatomy, Histology and Embryology, Semmelweis University Medical School, Budapest, Hungary 1450.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha</title>
</titleInfo>
<name type="personal">
<namePart type="given">Bálint</namePart>
<namePart type="family">Kacsóh</namePart>
<affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</affiliation>
<description>Permanent address: 2nd Department of Anatomy, Histology and Embryology, Semmelweis University Medical School, Budapest, Hungary 1450.</description>
<description>: B. Kacsóh, Pennsylvania State University, Department of Molecular and Cell Biology, 401 Althouse Laboratory, University Park, Pennsylvania 16802, USA.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Clark E.</namePart>
<namePart type="family">Grosvenor</namePart>
<affiliation>Department of Molecular and Cellular Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA.</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Blackwell Publishing Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1991-10</dateIssued>
<edition>Accepted 15 May 1991</edition>
<copyrightDate encoding="w3cdtf">1991</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="references">40</extent>
</physicalDescription>
<abstract lang="en">Various neural factors are involved in the suckling‐induced increase in serum growth hormone (GH) levels in neonatal rats, and, in the present study the serotonergic, cholinergic, somatostatin and GH‐releasing hormone (GHRH) systems were investigated. The serotonin (5‐HT) precursor 5‐hydroxy‐L‐tryptophan (5‐HTP) and the 5‐HT receptor agonist quipazine maleate stimulated serum GH levels in 2‐day‐old rat pups separated from their mothers for 6 h. The increase in serum GH during suckling was further elevated by 5‐HTP. The 5‐HT antagonist cyproheptadine decreased serum GH levels in separated 2‐day‐old pups, and although it reduced the amplitude of the suckling‐induced increase in serum GH concentration, it did not alter the increase in serum GH on a percentage basis. The effect of the cholinergic muscarinic antagonist atropine sulfate (ATR) was similar to that of cyproheptadine. Moreover, in separated pups, ATR prevented the increase in serum GH induced by 5‐HTP. In contrast with 2‐day‐old pups, ATR completely eliminated the suckling‐induced release of GH in 10‐day‐old rats. However, ATR failed to prevent GH release induced by the α2‐adrenergic agonist clonidine HCI in 10‐day‐old male pups. While thyrotropin‐releasing hormone increased serum GH levels, rat GHRH failed to alter serum GH levels either in separated or in suckled 2‐day‐old rat pups. Immunoneutralization for rat GHRH eliminated the increase in serum GH induced by clonidine HCI in 10‐day‐old pups, but (on a percentage basis) failed to prevent the GH‐increasing effect of suckling in 2‐day‐old pups. While somatostatin failed to significantly decrease serum GH in separated 2‐day‐old pups, it effectively decreased serum GH levels in 2‐day‐old pups which were suckled. Cysteamine, which depletes hypothalamic somatostatin, increased serum GH in separated 2‐day‐old pups, and further increased the suckling‐induced levels of serum GH. Cysteamine partially prevented the GH‐decreasing effect of ATR. The present findings suggest that 1) the serotonergic and cholinergic systems are involved in the regulation of GH secretion as early as day 2 postpartum; 2) the serotonergic and cholinergic systems modulate the basal, and do not modulate the suckling‐induced levels of serum GH; 3) the serotonergic system may exert its stimulatory influence on GH secretion only in the presence of a functional muscarinic cholinergic system; 4) the cholinergic system, at least in part, stimulates GH secretion via a cysteamine‐sensitive system (probably by inhibiting somatostatin); 5) the cholinergic system is not functionally coupled with the α2‐adrenergic system, which stimulates GH secretion via rat GHRH; 6) since in 10‐day‐old pups clonidine HCI was effective only in males, while suckling was effective in both sexes, the α2‐adrenergic system is not involved in the suckling‐induced increase of serum GH; and finally 7) neither somatostatin nor rat GHRH seem to be involved in the suckling‐induced changes in serum GH. The findings are consistent with the hypothesis that the high circulating GH levels in the neonatal rat are due to alternative GH‐releasing factors, perhaps thyrotropin‐releasing hormone or γ‐aminobutyric acid. The neurohumoral mediator of the suckling‐induced GH release in neonatal rats remains to be identified.</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>suckling</topic>
<topic>thyrotropin‐releasing hormone</topic>
<topic>Cysteamine</topic>
<topic>clonidine</topic>
<topic>sexual dimorphism</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Journal of Neuroendocrinology</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">0953-8194</identifier>
<identifier type="eISSN">1365-2826</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-2826</identifier>
<identifier type="PublisherID">JNE</identifier>
<part>
<date>1991</date>
<detail type="volume">
<caption>vol.</caption>
<number>3</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>529</start>
<end>537</end>
<total>9</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">FC96C32DDC748CD94C0DAA33E26278F261C4A295</identifier>
<identifier type="DOI">10.1111/j.1365-2826.1991.tb00314.x</identifier>
<identifier type="ArticleID">JNE529</identifier>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/ScrumV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C81 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002C81 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Informatique
   |area=    ScrumV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:FC96C32DDC748CD94C0DAA33E26278F261C4A295
   |texte=   Regulation of Basal and Nursing‐Induced Secretion of Growth Hormone in the Neonatal Rat: The Involvement of Serotonergic, Muscarinic Cholinergic, Alpha2‐Adrenergic, Somatostatin and Growth Hormone‐Releasing Hormone Systems
}}

Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Tue Mar 5 18:28:08 2024. Site generation: Tue Mar 5 18:45:01 2024